News

As the pharmaceutical industry is experiencing an economic turn down, the pharma giant meet to the discuss pharmaceutical futures. The pharma giants, GSK, Bayer, AstraZeneca, Novartis and Pfizer

With higher disposable incomes and changing attitudes towards healthcare, Indian consumers are buying more over-the-counter (OTC) drugs than before. While the total domestic OTC market size at INR21

YM BioSciences has reported total revenue of $5.6m for the fiscal year ended June 30, 2009, a decrease in comparison with $7.4m for fiscal year 2008. Fourth quarter

Merck & Co. has received a positive opinion from the EMEA’s Committee for Medicinal Products for Human Use (CHMP) for Januvia tablets and Janumet tablets recommending their use

Focetria, the Novartis Influenza A(H1N1) 2009 monovalent vaccine, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the EMEA. Reportedly, the

The FDA has granted accelerated approval for Allos Therapeutics’ FOLOTYN(pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell

Bioniche Pharma and Synerx Pharma, have launch of Fomepizole Injection, which is the generic equivalent of Paladin Labs’ Antizol. George Zorich, president for US Operations at Bioniche Pharma,

S&P Consultants and Vedant has entered into a business partnership, which to offer quality- and patient-safety assurance to both standard and customised applications built on the Cerner Millennium

Centocor Ortho Biotech has announced that the FDA has approved Stelara (ustekinumab) for the treatment of adult patients 18 years or older with moderate to severe plaque psoriasis